Drug Shortage Report for RAN-TADALAFIL

Last updated on 2021-01-31 History
Report ID 114215
Drug Identification Number 02452111
Brand name RAN-TADALAFIL
Common or Proper name TADALAFIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-01
Estimated end date 2021-01-15
Actual end date 2021-01-22
Shortage status Resolved
Updated date 2021-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-01-31 French Compare
v11 2021-01-31 English Compare
v10 2020-12-03 French Compare
v9 2020-12-03 English Compare
v8 2020-10-07 French Compare
v7 2020-10-07 English Compare
v6 2020-08-28 French Compare
v5 2020-08-28 English Compare
v4 2020-05-27 French Compare
v3 2020-05-27 English Compare
v2 2020-05-07 French Compare
v1 2020-05-07 English Compare

Showing 1 to 12 of 12